Disease Severity Modifier in the NICE Single Technology Appraisal of Trastuzumab Deruxtecan: External Assessment Group Perspective

  • Diarmuid Coughlan
  • , Oluwatomi Arisa
  • , Katie Thomson
  • , Ge Yu
  • , Fiona Pearson
  • , Ashleigh Kernohan
  • , Sonia Garcia Gonzalez-Moral
  • , Sheila Wallace
  • , Stephen Rice

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish
Pages (from-to)5-9
Number of pages5
JournalPharmacoEconomics
Volume42
Issue number1
DOIs
StatePublished - Jan 2024
Externally publishedYes

ASJC Scopus Subject Areas

  • Pharmacology
  • Health Policy
  • Public Health, Environmental and Occupational Health

Cite this